Systemic oxidative stress and conversion to dementia of elderly patients with mild cognitive impairment

Carlo Cervellati1, Arianna Romani1, Davide Seripa2

  • 1Section of Medical Biochemistry, Molecular Biology and Genetics, Department of Biomedical and Specialist Surgical Sciences, University of Ferrara, Via Borsari 46, 44121 Ferrara, Italy.

Insights

Oxidative stress (OxS) is elevated in mild cognitive impairment (MCI) and Alzheimer's disease (AD). However, serum OxS markers do not predict MCI progression to AD, suggesting OxS is an early feature, not a prognostic indicator.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Gerontology

Background:

  • Mild cognitive impairment (MCI) is a precursor to late-onset Alzheimer's disease (LOAD).
  • Oxidative stress (OxS) is hypothesized to play a role in LOAD pathogenesis.
  • Redox imbalance, including hydroperoxides and antioxidant capacity, may be linked to disease progression.

Purpose of the Study:

  • To investigate if serum OxS markers predict clinical progression from MCI to LOAD.
  • To assess serum hydroperoxide levels and antioxidant capacity in MCI, LOAD, and healthy controls.

Main Methods:

  • Serum hydroperoxide levels and antioxidant capacity were measured in 111 MCI patients, 105 LOAD patients, and 118 controls.
  • Multivariate analysis adjusted for age, gender, smoking, and comorbidities.
  • MCI patients were monitored for conversion to LOAD over 2.0 ± 0.6 years.

Main Results:

  • Baseline OxS levels were significantly increased in both MCI and LOAD groups compared to healthy controls (P < 0.05).
  • No significant differences in OxS markers were observed between MCI patients who converted to LOAD and those who did not.
  • Systemic OxS appears to be an early characteristic of MCI and LOAD.

Conclusions:

  • Elevated systemic oxidative stress is an early feature in mild cognitive impairment and Alzheimer's disease.
  • Current serum OxS markers are not predictive of progression from MCI to LOAD.
  • Further research is needed to clarify the prognostic role of oxidative stress in LOAD progression.

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
1.1K
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
687
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35